Activity of the highly specific RET inhibitor selpercatinib (LOXO-292) in pediatric patients with tumors harboring RET gene alterations Journal Article

   


Authors: Ortiz, M. V.; Gerdemann, U.; Raju, S. G.; Henry, D.; Smith, S.; Rothenberg, S. M.; Cox, M. C.; Proust, S.; Glade Bender, J.; Frazier, A. L.; Anderson, P.; Pappo, A. S.
Article Title: Activity of the highly specific RET inhibitor selpercatinib (LOXO-292) in pediatric patients with tumors harboring RET gene alterations
Journal Title: JCO Precision Oncology
Volume: 4
ISSN: 2473-4284
Publisher: American Society of Clinical Oncology  
Date Published: 2020-04-14
Start Page: 341
End Page: 347
Language: English
DOI: 10.1200/po.19.00401
PROVIDER: scopus
PMCID: PMC7450975
PUBMED: 32923911
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086464537&doi=10.1200%2fPO.19.00401&partnerID=40&md5=4e99e893b8e338b5d8b944e7908b31db
Notes: Article -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael Vincent Ortiz
    61 Ortiz
  2. Julia L Glade Bender
    85 Glade Bender
Related MSK Work